The launch comes a few months after the system picked up FDA clearance in March.
Northridge, California-based MiniMed, the former Medtronic Diabetes unit, designed Flex, its smallest insulin pump yet, as its first app-controlled pump. It launched the platform with the Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The company plans to roll it out with the Instinct sensor, made by Abbott, later this summer.
Flex comes in at roughly the size of two stacked insulin vials — about half the size of other MiniMed pumps. Still, it holds 300 units of insulin, fitting into everyday life no matter what a person wants to wear.
MiniMed says Flex offers its first screenless design, created in partnership with people living with diabetes. The company aimed to deliver an intuitive, lifestyle-friendly way to manage the condition. MiniMed’s SmartGuard algorithm with Meal Detection technology powers the pump.
Smartphone control through a compatible mobile app eliminates the traditional pump screen, the company says. It also offers seamless software updates through both iOS and Android devices at launch. The pump also has compatibility across two sensor options at launch to provide choices for users.
Flex works with MiniMed’s infusion set portfolio, including its Extended infusion set with up to seven days of wear. This enables up to 96% fewer injections compared with traditional insulin therapy, according to the company.
The pump is FDA-cleared for people with type 1 diabetes aged 7 and older, plus adults 18 and older with insulin-requiring type 2 diabetes.
Commentary from MiniMed officials and doctors
Que Dallara, CEO of MiniMed, said:
“For too long, people managing diabetes have had to choose between effective therapy and the freedom to just live their lives. MiniMed Flex changes that. It’s small enough to disappear, smart enough to handle the hard work, and now it’s in people’s hands. This is the MiniMed we’re becoming — faster, and more focused than ever on delivering on our mission. Better days start now.”
Dr. Anders Carlson, executive director, International Diabetes Center, and director, HealthPartners diabetes program; assistant professor, University of Minnesota Medical School, said:
“Having worked with people using MiniMed Flex, I’ve seen firsthand how app control can simplify everyday diabetes management. For many patients, two devices are central to daily life: their automated insulin delivery system and their phone. Bringing those experiences together, while continuing to leverage the trusted MiniMed algorithm, represents a meaningful evolution in how diabetes technology can support people throughout the day.”
